STANFORD UNIVERSITY
Investigating evolutionary antagonism between tumors and lymphocytes
Investigating evolutionary antagonism between tumors and lymphocytes is a funding opportunity from STANFORD UNIVERSITY, up to 49538, closing August 31, 2028.
Aug 31, 2028
(762d left)Overview
PROJECT SUMMARY Metastasis accounts for the majority of cancer patient deaths and even though immune checkpoint blockade has proven effective in many malignancies, metastatic disease remains resistant to therapy. Cancer metastasis is an inefficient process, requiring cancer cells to disseminate from primary tumors to…